Pathway Map Details
Immune response_BCR pathway
Object list (links open in MetaCore):
BAD, CD22, Bcl-XL, PI3K reg class IA, 126.96.36.199, VAV-1, Rac1, AKT(PKB), CD79 complex, VAV-2, Bcl-6, DAG, Shc, GRB2, PtdIns(3,4,5)P3, Ca('2+) cytosol, Erk (MAPK1/3), 188.8.131.52, CD81,
BCR signaling pathway
The BCR (B-Cell antigen Receptor) plays a critical role in development, survival, and activation of B lymphocytes. The BCR is composed of membrane immunoglobulin ( IgM ) molecules associated with CD79a molecule, immunoglobulin-associated alpha - CD79b molecule, immunoglobulin-associated beta heterodimers ( CD79 complex ) . The IgM subunits bind antigens and cause receptor aggregation, while the CD79 complex subunits transduce intracellular signaling cascades. Upon activation, BCRs activate the Spleen tyrosine kinase ( Syk ) and v-yes-1 Yamaguchi sarcoma viral related oncogene homolog ( Lyn ), which phosphorylate and activate Phospholipases C, gamma ( PLC-gamma ), and Bruton agammaglobulinemia tyrosine kinase ( BTK ), respectively. BTK also activates both PLC-gamma isoforms , .
Once activated, these tyrosine kinases phosphorylate activate several signaling pathways, including Ras-ERK and PLC-gamma signal cascades, which lead to the activation of transcription factors, such as ELK1, member of ETS oncogene family ( ELK1 ), Early growth response 1 ( EGR1 ), Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 ( NF-AT1(NFATC2) ) and Nuclear factor of kappa light polypeptide gene enhancer in B-cells ( NF-kB ), and inhibit transcription factors, such as B-cell CLL/lymphoma 6 ( Bcl-6 ).
PLC-gamma activation that is mediated by BTK and B-cell linker ( BLNK ), leads to the conversion of phosphatidylinositol-4,5-biphosphate ( PtdIns(4,5)P2 ) to the second messengers inositol-1,4,5-trisphosphate ( IP3 ) and Diacylglycerol ( DAG ). IP3 binds to Inositol 1,4,5-triphosphate receptor ( IP3 Receptor ), which is localized primarily on the endoplasmic reticulum and stimulates the release of calcium from intracellular stores. Calcium-bound Calmodulin 2 ( Calmodulin ) associates with and activates Protein phosphatase 3, catalytic subunit ( Calcineurin A (catalytic) ). Calcineurin A (catalytic) dephosphorylates NF-AT1(NFATC2) leading to theirs translocation to the nucleus .
DAG activates Protein kinase C, beta ( PKC-beta ). PKC-beta in particular, is a critical component of the BCR signalosome, and is essential for recruitment and activation of the IKK complex resulting in the translocation of NF-kB to the nucleus .
Several transmembrane receptors are known to modulate specific elements of BCR signaling. These include Protein tyrosine phosphatase, receptor type, C ( CD45 ) and Fc fragment of IgG, low affinity IIb, receptor ( Fc gamma RII beta ). CD45 has its own protein tyrosine phosphatase activity and inhibits v-yes-1 Yamaguchi sarcoma viral related oncogene homolog ( Lyn ) activity by dephosphorylation leading to reduction in CD45 's negative regulatory effects , .
Lyn phosphorylates and activates co-receptor CD19 molecule ( CD19 ) and receptor Fc-gamma-RII , . CD19 is a cell surface molecule, which assembles with the antigen receptor of B lymphocytes in order to decrease the threshold for antigen receptor-dependent stimulation. This co-receptor complex is composed of CD19, Complement component receptor 2 ( CD21 ) and CD81 molecule ( CD81 ) . CD21 binds to opsinized antigenic particles and is primarily responsible for signal transduction. Phosphorylation of CD19 by Lyn generates binding sites for Phosphoinositide-3-kinase, catalytic ( PI3K cat class IA ). PI3K cat class IA activates Phosphatidylinositol-3,4,5-triphosphate ( PtdIns(3,4,5)P3 ) and Vav 1 and 2 guanine nucleotide exchange factors ( VAV-1 and VAV-2). The CD19 co-receptor physically interacts with VAV-1 and VAV-2 and synergistically enhances their phosphorylation induced by the BCR. VAV-1 and VAV-2 activate small GTP binding proteins Ras-related C3 botulinum toxin substrate 1 ( Rac1 ) and cell division cycle 42 ( CDC42 ) .
PtdIns(3,4,5)P3 associates with the inner phospholipid bilayer of the plasma membrane to promote the recruitment of pleckstrin homology (PH) domain-rich proteins such as 3-phosphoinositide dependent protein kinase-1 ( PDK (PDPK1) ) and V-akt murine thymoma viral oncogene homolog 1 ( AKT(PKB) ). PDK (PDPK1) activates AKT(PKB), which phosphorylates downstream target including BCL2 Antagonist of Cell Death ( BAD ), Glycogen synthase kinase 3 beta ( GSK3 beta ) and Ribosomal protein S6 kinase, 70kDa, polypeptide 1 ( P70 S6 kinase1 ), thereby regulating apoptosis, cell cycle, cell growth and other cellular processes .
Fc-gamma-RII activates the Inositol polyphosphate-5-phosphatase, 145kDa ( SHIP ). SHIP converts PtdIns(3,4,5)P3 into PtdIns (3,4)P2, which is the second messenger that activates PDK (PDPK1) and AKT(PKB) .
Lyn also participates in the negative regulation of BCR signaling. Lyn phosphorylates CD22 molecule ( CD22 ), which binds to the Protein tyrosine phosphatase, non-receptor type 6 ( SHP-1 ) and induces Lyn dephosphorylation by SHP-1, thereby down-regulating Btk -dependent IP3 production and calcium mobilization , .
- Geisberger R, Crameri R, Achatz G
Models of signal transduction through the B-cell antigen receptor. Immunology 2003 Dec;110(4):401-10
- Pao LI, Cambier JC
Syk, but not Lyn, recruitment to B cell antigen receptor and activation following stimulation of CD45- B cells. Journal of immunology (Baltimore, Md. : 1950) 1997 Mar 15;158(6):2663-9
- Mohamed AJ, Nore BF, Christensson B, Smith CI
Signalling of Bruton's tyrosine kinase, Btk. Scandinavian journal of immunology 1999 Feb;49(2):113-8
- Hogan PG, Chen L, Nardone J, Rao A
Transcriptional regulation by calcium, calcineurin, and NFAT. Genes & development 2003 Sep 15;17(18):2205-32
- Guo B, Su TT, Rawlings DJ
Protein kinase C family functions in B-cell activation. Current opinion in immunology 2004 Jun;16(3):367-73
- Harashima A, Suzuki M, Okochi A, Yamamoto M, Matsuo Y, Motoda R, Yoshioka T, Orita K
CD45 tyrosine phosphatase inhibits erythroid differentiation of umbilical cord blood CD34+ cells associated with selective inactivation of Lyn. Blood 2002 Dec 15;100(13):4440-5
- Shrivastava P, Katagiri T, Ogimoto M, Mizuno K, Yakura H
Dynamic regulation of Src-family kinases by CD45 in B cells. Blood 2004 Feb 15;103(4):1425-32
- Malbec O, Fong DC, Turner M, Tybulewicz VL, Cambier JC, Fridman WH, Daeron M
Fc epsilon receptor I-associated lyn-dependent phosphorylation of Fc gamma receptor IIB during negative regulation of mast cell activation. Journal of immunology (Baltimore, Md. : 1950) 1998 Feb 15;160(4):1647-58
- Somani AK, Yuen K, Xu F, Zhang J, Branch DR, Siminovitch KA
The SH2 domain containing tyrosine phosphatase-1 down-regulates activation of Lyn and Lyn-induced tyrosine phosphorylation of the CD19 receptor in B cells. The Journal of biological chemistry 2001 Jan 19;276(3):1938-44
- Mongini PK, Jackson AE, Tolani S, Fattah RJ, Inman JK
Role of complement-binding CD21/CD19/CD81 in enhancing human B cell protection from Fas-mediated apoptosis. Journal of immunology (Baltimore, Md. : 1950) 2003 Nov 15;171(10):5244-54
- O'Rourke LM, Tooze R, Turner M, Sandoval DM, Carter RH, Tybulewicz VL, Fearon DT
CD19 as a membrane-anchored adaptor protein of B lymphocytes: costimulation of lipid and protein kinases by recruitment of Vav. Immunity 1998 May;8(5):635-45
- Katso R, Okkenhaug K, Ahmadi K, White S, Timms J, Waterfield MD
Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer. Annual review of cell and developmental biology 2001;17:615-75
- Lemmon MA
Phosphoinositide recognition domains. Traffic (Copenhagen, Denmark) 2003 Apr;4(4):201-13
- Fluckiger AC, Li Z, Kato RM, Wahl MI, Ochs HD, Longnecker R, Kinet JP, Witte ON, Scharenberg AM, Rawlings DJ
Btk/Tec kinases regulate sustained increases in intracellular Ca2+ following B-cell receptor activation. The EMBO journal 1998 Apr 1;17(7):1973-85
- Poe JC, Fujimoto Y, Hasegawa M, Haas KM, Miller AS, Sanford IG, Bock CB, Fujimoto M, Tedder TF
CD22 regulates B lymphocyte function in vivo through both ligand-dependent and ligand-independent mechanisms. Nature immunology 2004 Oct;5(10):1078-87